CONSISTENCY OF FRIEDEWALD, MARTIN/HOPKINS AND SAMSON FORMULAS FOR LDL-C CALCULATION IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS

被引:0
|
作者
Basaran, O. [1 ]
Dogan, V. [1 ]
Celik, O. [1 ]
Cil, C. [2 ]
Ozlek, B. [2 ]
Ozlek, E. [2 ]
Ozdemir, I. H. [3 ]
Rencuzogullari, I. [4 ]
Karadeniz, F. [5 ]
Tekinalp, M. [6 ]
Askin, L. [7 ]
Demirelli, S. [5 ]
Gencer, E. [8 ]
Biteker, M. [1 ]
Kayikcioglu, M. [9 ]
机构
[1] Mugla Sitki Kocman Univ, Cardiol, Mugla, Turkey
[2] Mugla Sitki Kocman Univ Educ & Res Hosp, Cardiol, Mugla, Turkey
[3] Nizip State Hosp, Cardiol, Gaziantep, Turkey
[4] Kars Univ, Cardiol, Kars, Turkey
[5] Erzurum Educ & Res Hosp, Cardiol, Erzurum, Turkey
[6] Necip Fazil State Hosp, Cardiol, Kahramanmaras, Turkey
[7] Adiyaman Univ, Cardiol, Adiyaman, Turkey
[8] Kilis State Hosp, Cardiol, Kilis, Turkey
[9] Ege Univ, Cardiol, Sch Med, Izmir, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP231
引用
收藏
页码:E160 / E160
页数:1
相关论文
共 50 条
  • [1] COMPARISON OF CALCULATED LDL-C LEVELS (FRIEDEWALD AND MARTIN/HOPKINS ESTIMATION) IN ATHEROGENIC DYSLIPIDEMIA CONDITION
    Reiber, I.
    Mark, L.
    Bajnok, L.
    Paragh, G.
    ATHEROSCLEROSIS, 2020, 315 : E70 - E70
  • [2] Comparison of LDL-C calculation by friedewald and martin/hopkins methods in 12,243 adults from the United States of America
    Penson, P.
    Martin, S. S.
    Henney, N. C.
    Banach, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2932 - 2932
  • [3] STATIN TREATED PATIENTS AT VERY HIGH CARDIOVASCULAR RISK IN EUROPE: ARE THE MAJORITY CLOSE TO LDL-C
    Lautsch, D.
    Gitt, A. K.
    Brudi, P.
    Vanneste, B.
    Ambegaonkar, B.
    ATHEROSCLEROSIS, 2014, 235 (02) : E35 - E35
  • [4] LDL-C TREATMENT GAPS IN STATIN-TREATED PATIENTS AT HIGH AND VERY HIGH CARDIOVASCULAR RISK IN EUROPE
    Gitt, A. K.
    Ambegaonkar, B.
    Brudi, P.
    Lautsch, D.
    ATHEROSCLEROSIS, 2014, 235 (02) : E106 - E106
  • [5] Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study
    Gavina, Cristina
    Seabra-Carvalho, Daniel
    Aguiar, Carlos
    Anastassopoulou, Anastassia
    Teixeira, Carla
    Ruivo, Jorge A.
    Almeida, Elia
    Luz-Duarte, Leonor
    Corte-Real, Ana
    Canelas-Pais, Mariana
    Taveira-Gomes, Tiago
    CLINICAL CARDIOLOGY, 2024, 47 (01)
  • [6] LDL-C GOALS ATTAINMENT IN PATIENTS AT VERY HIGH CARDIOVASCULAR RISK: A MULTICENTRIC RWE EVALUATION IN COLOMBIA
    Cordoba, B.
    Giraldo, H. Leon
    Quintero, V
    Sabogal, J.
    Ayala, M.
    Buitrago, A. F.
    Herrera, A.
    Zarate, J.
    Cruz, J.
    Velasquez, J.
    Ordonez, P. Rodriguez
    Albaran, C.
    Rodriguez, M. Rojas
    Londono, S.
    Mesa, J. Gomez
    VALUE IN HEALTH, 2024, 27 (12)
  • [7] Cardiovascular Outcomes of Early LDL-C Goal Achievement in Patients with Very-High-Risk ASCVD
    Kim, Ah-Ram
    Han, Ji Ye
    Kim, Minkyoung
    Lee, Hojoon
    Baek, Yeon-Hee
    Ahn, Imjin
    Kang, Hee Jun
    Oh, Ji Seon
    Kim, Ju Hyeon
    Kwon, Osung
    Jun, Tae Joon
    Kwon, Sun U.
    Kim, Young-Hak
    CARDIOLOGY AND THERAPY, 2025, 14 (01) : 101 - 115
  • [8] Statin treated patients at very high cardiovascular risk: Are the majority close to LDL-C < 70 mg/dl?
    Gitt, A. K.
    Ambegaonkar, B.
    Brudi, P.
    Horack, M.
    Vanneste, B.
    Lautsch, D.
    EUROPEAN HEART JOURNAL, 2014, 35 : 679 - 679
  • [9] Extensive Evidence Supports the Martin-Hopkins Equation as the LDL-C Calculation of Choice
    Grant, Jelani K.
    Kaufman, Harvey W.
    Martin, Seth S.
    CLINICAL CHEMISTRY, 2024, 70 (02) : 361 - 367
  • [10] Undertreatment and Underachievement of LDL-C Target among Individuals with High and Very High Cardiovascular Risk in the Malaysian Community
    Razman, Aimi Zafira
    Baharudin, Noorhida
    Mohd Kasim, Noor Alicezah
    Al-Khateeb, Alyaa
    Ismail, Zaliha
    Nawawi, Hapizah
    HEALTHCARE, 2022, 10 (12)